Nan Fung Group Holdings’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,642
Closed -$209K 43
2022
Q3
$209K Buy
+5,642
New +$209K 0.13% 31